INMB
Price
$2.56
Change
-$0.16 (-5.86%)
Updated
Aug 1, 04:59 PM (EDT)
Capitalization
69.87M
88 days until earnings call
MTNB
Price
$0.87
Change
-$0.01 (-1.14%)
Updated
Aug 1, 02:33 PM (EDT)
Capitalization
4.43M
Interact to see
Advertisement

INMB vs MTNB

Header iconINMB vs MTNB Comparison
Open Charts INMB vs MTNBBanner chart's image
INmune Bio
Price$2.56
Change-$0.16 (-5.86%)
Volume$2.02K
Capitalization69.87M
Matinas Biopharma Holdings
Price$0.87
Change-$0.01 (-1.14%)
Volume$200
Capitalization4.43M
INMB vs MTNB Comparison Chart in %
Loading...
INMB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MTNB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Regeneron Pharmaceuticals (NASDAQ:REGN), Incyte Corp (NASDAQ:INCY), Moderna (NASDAQ:MRNA), Exelixis (NASDAQ:EXEL), Arrowhead Pharmaceuticals (NASDAQ:ARWR), BioCryst Pharmaceuticals (NASDAQ:BCRX), Adaptive Biotechnologies Corp (NASDAQ:ADPT), Sarepta Therapeutics (NASDAQ:SRPT), Novavax (NASDAQ:NVAX), Nektar Therapeutics (NASDAQ:NKTR).

Industry description

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

Market Cap

The average market capitalization across the Biotechnology Industry is 2.34B. The market cap for tickers in the group ranges from 58 to 213.98B. NONOF holds the highest valuation in this group at 213.98B. The lowest valued company is SEELQ at 58.

High and low price notable news

The average weekly price growth across all stocks in the Biotechnology Industry was 1%. For the same Industry, the average monthly price growth was 17%, and the average quarterly price growth was 37%. SLXN experienced the highest price growth at 1,575%, while ADAP experienced the biggest fall at -76%.

Volume

The average weekly volume growth across all stocks in the Biotechnology Industry was -7%. For the same stocks of the Industry, the average monthly volume growth was 38% and the average quarterly volume growth was 123%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 50
P/E Growth Rating: 83
Price Growth Rating: 57
SMR Rating: 92
Profit Risk Rating: 95
Seasonality Score: -11 (-100 ... +100)

Market Cap

The average market capitalization across the group is 38.64M. The market cap for tickers in the group ranges from 4.27M to 73M. INMB holds the highest valuation in this group at 73M. The lowest valued company is MTNB at 4.27M.

High and low price notable news

The average weekly price growth across all stocks in the group was -5%. For the same group, the average monthly price growth was 14%, and the average quarterly price growth was -11%. INMB experienced the highest price growth at -2%, while MTNB experienced the biggest fall at -7%.

Volume

The average weekly volume growth across all stocks in the group was 4%. For the same stocks of the group, the average monthly volume growth was -57% and the average quarterly volume growth was -22%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 53
P/E Growth Rating: 100
Price Growth Rating: 59
SMR Rating: 98
Profit Risk Rating: 100
Seasonality Score: -67 (-100 ... +100)
VS
INMB vs. MTNB commentary
Aug 02, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is INMB is a Hold and MTNB is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 02, 2025
Stock price -- (INMB: $2.73 vs. MTNB: $0.88)
Brand notoriety: INMB and MTNB are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: INMB: 25% vs. MTNB: 10%
Market capitalization -- INMB: $69.87M vs. MTNB: $4.43M
INMB [@Biotechnology] is valued at $69.87M. MTNB’s [@Biotechnology] market capitalization is $4.43M. The market cap for tickers in the [@Biotechnology] industry ranges from $213.98B to $0. The average market capitalization across the [@Biotechnology] industry is $2.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MTNB’s FA Score shows that 1 FA rating(s) are green whileINMB’s FA Score has 0 green FA rating(s).

  • MTNB’s FA Score: 1 green, 4 red.
  • INMB’s FA Score: 0 green, 5 red.
According to our system of comparison, MTNB is a better buy in the long-term than INMB.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

INMB’s TA Score shows that 4 TA indicator(s) are bullish while MTNB’s TA Score has 5 bullish TA indicator(s).

  • INMB’s TA Score: 4 bullish, 4 bearish.
  • MTNB’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, MTNB is a better buy in the short-term than INMB.

Price Growth

INMB (@Biotechnology) experienced а -1.97% price change this week, while MTNB (@Biotechnology) price change was -7.37% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.32%. For the same industry, the average monthly price growth was +16.82%, and the average quarterly price growth was +37.20%.

Reported Earning Dates

INMB is expected to report earnings on Oct 29, 2025.

MTNB is expected to report earnings on Apr 15, 2025.

Industries' Descriptions

@Biotechnology (+1.32% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
INMB($69.9M) has a higher market cap than MTNB($4.43M). MTNB YTD gains are higher at: 72.549 vs. INMB (-41.645). MTNB has higher annual earnings (EBITDA): -15.35M vs. INMB (-41.52M). INMB has more cash in the bank: 19.3M vs. MTNB (6.92M). INMB has less debt than MTNB: INMB (347K) vs MTNB (2.71M). INMB has higher revenues than MTNB: INMB (50K) vs MTNB (0).
INMBMTNBINMB / MTNB
Capitalization69.9M4.43M1,579%
EBITDA-41.52M-15.35M271%
Gain YTD-41.64572.549-57%
P/E RatioN/AN/A-
Revenue50K0-
Total Cash19.3M6.92M279%
Total Debt347K2.71M13%
FUNDAMENTALS RATINGS
MTNB vs INMB: Fundamental Ratings
MTNB
INMB
OUTLOOK RATING
1..100
8215
VALUATION
overvalued / fair valued / undervalued
1..100
24
Undervalued
83
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9998
PRICE GROWTH RATING
1..100
5365
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

MTNB's Valuation (24) in the Biotechnology industry is somewhat better than the same rating for INMB (83). This means that MTNB’s stock grew somewhat faster than INMB’s over the last 12 months.

MTNB's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as INMB (100). This means that MTNB’s stock grew similarly to INMB’s over the last 12 months.

INMB's SMR Rating (98) in the Biotechnology industry is in the same range as MTNB (99). This means that INMB’s stock grew similarly to MTNB’s over the last 12 months.

MTNB's Price Growth Rating (53) in the Biotechnology industry is in the same range as INMB (65). This means that MTNB’s stock grew similarly to INMB’s over the last 12 months.

MTNB's P/E Growth Rating (100) in the Biotechnology industry is in the same range as INMB (100). This means that MTNB’s stock grew similarly to INMB’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
INMBMTNB
RSI
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
87%
Bullish Trend 2 days ago
82%
Momentum
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 2 days ago
89%
MACD
ODDS (%)
Bullish Trend 2 days ago
84%
Bearish Trend 2 days ago
81%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
82%
Bearish Trend 2 days ago
89%
Advances
ODDS (%)
Bullish Trend 4 days ago
83%
Bullish Trend 23 days ago
80%
Declines
ODDS (%)
Bearish Trend 8 days ago
87%
Bearish Trend 3 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
82%
Bullish Trend 2 days ago
76%
Aroon
ODDS (%)
N/A
N/A
View a ticker or compare two or three
Interact to see
Advertisement
INMB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MTNB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SRBK13.94-0.01
-0.07%
SR Bancorp
AVAH3.97-0.02
-0.50%
Aveanna Healthcare Holdings
SNEX97.24-0.56
-0.57%
StoneX Group Inc
IBKR65.56-0.66
-1.00%
Interactive Brokers Group Inc
FFAI2.12-0.21
-9.19%
Faraday Future Intelligent Electric Inc

INMB and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, INMB has been loosely correlated with ORMP. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if INMB jumps, then ORMP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INMB
1D Price
Change %
INMB100%
+1.69%
ORMP - INMB
38%
Loosely correlated
+0.47%
AXON - INMB
37%
Loosely correlated
+0.97%
ABCL - INMB
36%
Loosely correlated
-2.19%
PROK - INMB
35%
Loosely correlated
+3.53%
CGEN - INMB
34%
Loosely correlated
+1.04%
More

MTNB and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, MTNB has been loosely correlated with EQ. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if MTNB jumps, then EQ could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MTNB
1D Price
Change %
MTNB100%
+4.76%
EQ - MTNB
39%
Loosely correlated
+0.74%
ABCZF - MTNB
37%
Loosely correlated
N/A
SPRC - MTNB
35%
Loosely correlated
-8.92%
AXON - MTNB
34%
Loosely correlated
+0.97%
VKTX - MTNB
32%
Poorly correlated
-3.38%
More